Skip to content

Clinical trials

Granulomatous Disease, Chronic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Granulomatous Disease, Chronic Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20011
20021
20044
20051
20063
20072
20081
20091
20104
20112
20121
20137
20147
20154
20161
20172
20183
20193
20201
20211
20224
20234
20245
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Terminated14
Recruiting11
Unknown status7
Active, not recruiting6
Withdrawn5
Enrolling by invitation4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)30
Paul Szabolcs4
Children's Hospital Los Angeles2
Children's Hospital of Fudan University2
Emory University2
Ensoma2
Federal Research Institute of Pediatric Hematology, Oncology and Immunology2
Genethon2
University of Colorado, Denver2
Baylor College of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Granulomatous Disease, Chronic78
Wiskott-Aldrich Syndrome13
Anemia, Sickle Cell10
Chediak-Higashi Syndrome10
Lymphohistiocytosis, Hemophagocytic10
Severe Combined Immunodeficiency10
Anemia, Diamond-Blackfan9
Immunologic Deficiency Syndromes7
Inflammatory Bowel Diseases7
Mucopolysaccharidosis I7

Trials

Showing 76 to 78 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.